NCT07277803

Brief Summary

Chronic low back pain (CLBP) is a leading cause of disability worldwide and affects a large proportion of working-age individuals. Cortical reorganization in CLBP, particularly within the sensorimotor cortex, has been shown to negatively influence sensory acuity and motor control. The neuroplasticity underlying this reorganization may enhance the effectiveness of sensorimotor retraining therapies that involve specific stimulus features targeting somatosensory cortical regions. This randomized controlled trial will include three groups: a device-assisted sensory acuity training group, a manual sensory acuity training group, and a control group receiving conventional physiotherapy. In this study, device-assisted sensory acuity training will be delivered using a standardized vibrotactile interface that presents controlled stimuli and records participant responses. The intervention will be structured to target sensory acuity components similar to those addressed in manual training. Accordingly, the structured training protocol will include:

  • localization training to improve detection of stimulus location,
  • orientation discrimination to identify stimulus direction,
  • temporal acuity training to distinguish timing differences between tactile stimuli and
  • graphesthesia training to improve recognition of shapes or letters drawn on the skin through tactile input. The primary aim of this study is to evaluate sensory acuity in individuals with CLBP and to determine the effects of a structured manual and technology-based sensory acuity training program, combined with conventional physiotherapy, on pain intensity (VAS), lumbar two-point discrimination, and a composite sensory acuity score. We hypothesize that adding manual and technology-based structured sensory acuity training (SAT) program to a conventional physiotherapy regimen including motor control exercises will support central nervous system reorganization, improve sensory profiles, and lead to improvements in pain-related variables, disability, and quality of life. Through this structured SAT program, we aim to provide an approach that evaluates and trains multiple dimensions of sensory acuity in CLBP, including localization, orientation, and temporal discrimination.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable low-back-pain

Timeline
16mo left

Started Aug 2026

Typical duration for not_applicable low-back-pain

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2025

Completed
7 months until next milestone

First Posted

Study publicly available on registry

December 11, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

August 15, 2026

Expected
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2027

7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2027

Last Updated

May 13, 2026

Status Verified

December 1, 2025

Enrollment Period

9 months

First QC Date

May 27, 2025

Last Update Submit

May 12, 2026

Conditions

Keywords

Chronic painphysiotherapy and rehabilitationradial/local vibrationlow back painpain treatmenttactile feedbackmobile applicationswearable technologiesembedded system design

Outcome Measures

Primary Outcomes (4)

  • Visual Analog Scale (VAS)

    In order to evaluate the pain levels of the participants, the average pain intensity in the last 7 days will be evaluated with the Visual Analog Scale (VAS).

    Baseline (prior to the intervention), end of treatment (after the 12th session), and 6 months post-treatment.

  • Two-Point Discrimination Test (TPDT)

    TPDT skill levels of individuals with CLI will be measured using a commercially available mechanical aesthesiometer (Baseline, 12-1480 Aesthesiometer).

    Baseline (prior to the intervention), end of treatment (after the 12th session), and 6 months post-treatment.

  • Sensory Acuity Composite Score

    Localization, orientation, and temporal acuity accuracy (%) will be calculated by taking the average value of the sum of the levels. Evaluations will be made using the thick end of the monofilament. Each application will be performed in two sets of 20 repetitions in random order, each set including location, direction, and number of stimuli. Localization accuracy will be assessed using a locognosy test, which measures the percentage of correct responses by touching areas numbered 1 to 16 on a 4x4 grid, with participants pointing to the correct point on the figure.

    Baseline (prior to the intervention), end of treatment (after the 12th session), and 6 months post-treatment.

  • Roland Morris Disability Questionnaire (RMDQ)

    The Roland Morris Disability Questionnaire (RMDQ), consisting of 24 questions focusing on regular activities of daily living, will be used to assess participants' disability levels. The total score ranges from 0 to 24, with higher scores reflecting increasing disability and scores exceeding 14 indicating severe disability.

    Baseline (prior to the intervention), end of treatment (after the 12th session), and 6 months post-treatment.

Secondary Outcomes (8)

  • Pain Pressure Threshold (PPT)

    Baseline (prior to the intervention), end of treatment (after the 12th session), and 6 months post-treatment.

  • Left-Right Judgment Task (LRJT)

    Baseline (prior to the intervention), end of treatment (after the 12th session), and 6 months post-treatment.

  • Tampa Kinesiophobia Scale (TKS)

    Baseline (prior to the intervention), end of treatment (after the 12th session), and 6 months post-treatment.

  • Pain Catastrophizing Scale (PCS)

    Baseline (prior to the intervention), end of treatment (after the 12th session), and 6 months post-treatment.

  • Joint Position Sense (JPS)

    Baseline (prior to the intervention), end of treatment (after the 12th session), and 6 months post-treatment.

  • +3 more secondary outcomes

Study Arms (3)

Manual Sensory Acuity Training Group (M-SATG)

EXPERIMENTAL

In addition to motor control exercises, individuals with NLBP included in the M-SATG will receive sensory acuity training with progressively increasing levels of difficulty. This training will include manually administered components of localization acuity, orientation acuity, temporal acuity, and graphesthesia. All sensory acuity components (localization, orientation, temporal acuity, graphesthesia) will be delivered in randomized sequences generated prior to each session. During localization, orientation, and temporal acuity tasks, a standardized adhesive grid template consisting of 16 points will be applied to the lumbar region to guide stimulus delivery. Throughout the training process, participants will progress to the next training stage once they achieve 80% accuracy for that week. A response interval of 10 seconds will be provided between stimuli, with 1 minute rest periods between training sets and 2 minute rest periods between different training parameters.

Other: Manual Sensory Acuity Training Group (M-SATG)

Control Group (CG)

EXPERIMENTAL

All individuals in this group will receive Motor Control Exercises (MCEs) for 30 minutes to promote correct muscle activation, postural alignment, movement integrity, and optimal control of the spine and pelvis. In addition to MCEs, participants will also receive a structured 30-minute patient education (PE) program, matched to the duration of the structured SAT program administered in the other groups. The PE program will focus on developing safe movement strategies, postural awareness, ergonomics, and self-management skills.

Other: Control Group (CG)

Technology-Based Sensory Acuity Training Group (T-SATG)

EXPERIMENTAL

Participants in this arm will receive technology-based sensory acuity training delivered through the TactiPain device in addition to motor control exercises. The training will include vibrotactile localization, orientation, temporal acuity, and graphesthesia tasks administered with a progressive weekly protocol. Vibrotactile stimuli will be presented through a 4×4 matrix of 16 vibration motors positioned over the lumbar region, with weekly progression in intensity, vibration duration, and inter-stimulus intervals. Randomized sequences will be used for all tasks, and progression will occur when ≥80% accuracy is achieved. A response interval of 10 seconds will be provided between stimuli, with 1 minute rest periods between training sets and 2 minute rest periods between different training parameters.

Device: Technology-Based Sensory Acuity Training Group (T-SATG)

Interventions

The MCE program will follow a progressive approach targeting activation of the transversus abdominis and multifidus muscles. It will begin with basic exercises emphasizing isolated contractions and progress to more complex movements involving co-activation of both muscles, including bridging and quadruped exercises. As part of the PE component, participants will receive fundamental information regarding spinal health, neutral spine posture, and appropriate movement strategies for daily activities. Guidance will be provided on ergonomics, including lifting techniques, workspace organization, and methods to reduce mechanical load on the lower back. The program will also support self-care by promoting regular physical activity, appropriate pacing during flare-ups, adequate rest, and healthy lifestyle habits.

Control Group (CG)

To progressively increase difficulty, Semmes-Weinstein monofilaments with thick and thin tips will be used to vary stimulus pressure. Stimulus duration will advance weekly: week 1 - thick tip 5 s, week 2 - thick tip 2 s, week 3 - thin tip 5 s, week 4 - thin tip 2 s, with a stopwatch ensuring standardization and fixed intervals between stimuli. All sensory acuity tasks (localization, orientation, temporal acuity, and graphesthesia) will be delivered using randomized sets generated by random.org to prevent habituation. Responses will be recorded weekly to track progress. An adhesive 16-hole grid template will be placed between the last rib and sacrum on each participant before each session.

Manual Sensory Acuity Training Group (M-SATG)

The vibrotactile stimuli will be delivered according to a predefined weekly progression. In Week 1, high-intensity vibrations will be applied with a duration of 500 ms and an inter-stimulus interval of 1 second. In Week 2, medium-intensity vibrations will be delivered with a duration of 500 ms and a 500-ms inter-stimulus interval. In Week 3, medium-intensity vibrations will be delivered with a duration of 200 ms and a 200-ms inter-stimulus interval, and in Week 4, low-intensity vibrations will be applied with a duration of 100 ms and a 100-ms inter-stimulus interval. This structured progression is designed to ensure a gradual increase in task difficulty and to standardize the vibrotactile training across participants.

Technology-Based Sensory Acuity Training Group (T-SATG)

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 25-45 years
  • No spinal fracture or acute disc herniation
  • Pain duration ≥ 3 months
  • Pain intensity ≥ 4/10
  • Central Sensitization Scale (CSI) score ≥ 40
  • No current psychiatric illness or cognitive impairment
  • No contraindications to exercise

You may not qualify if:

  • Serious spinal pathologies (lumbar stenosis, spondylolisthesis, tumor, infection, metastasis, osteoporotic fracture, severe structural deformities, inflammatory arthritis)
  • Conditions with radicular involvement or neurological deficits (sciatica, nerve root compression)
  • Systemic or neurological diseases (diabetes mellitus, neuromuscular diseases, serious central or peripheral nervous system diseases, epilepsy)
  • Mental disorders
  • Pregnancy
  • Lower extremity injuries
  • Spinal surgery within the last three years
  • Chronic generalized pain syndromes (fibromyalgia, chronic fatigue syndrome)
  • Individuals receiving other treatment for non-specific chronic low back pain during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Low Back PainChronic PainAgnosia

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • AYSE GURLUK, PhD (c)

    Medipol University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

AYSE GURLUK, PhD (c)

CONTACT

PINAR KAYA SARİBAS, ASSOCIATE PROFESSOR

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is an interventional randomized controlled trial with parallel assignment. The study was designed as a single-blind study; only the clinical evaluator will be blinded. Participants and therapists administering the intervention will not be blinded due to the nature of the intervention. The evaluator's lack of knowledge about group assignments was planned to ensure objectivity of the measurements and minimize the risk of bias. Patients and the public were not involved in the design or conduct of this trial. The study design and intervention protocols were informed by existing scientific evidence and clinical guidelines. Participant burden was considered in determining session duration and assessment procedures. Participants will not be involved in the interpretation or dissemination of the study findings.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

May 27, 2025

First Posted

December 11, 2025

Study Start (Estimated)

August 15, 2026

Primary Completion (Estimated)

May 15, 2027

Study Completion (Estimated)

December 15, 2027

Last Updated

May 13, 2026

Record last verified: 2025-12